Informations générales (source: ClinicalTrials.gov)
Validation and Optimization Methods for a Quantitative Characterization of Motion Abnormalities of the Larynx With Echography
Interventional
N/A
Assistance Publique - Hôpitaux de Paris (Voir sur ClinicalTrials)
octobre 2019
avril 2024
12 septembre 2025
One of the major risks of endocrine surgery is recurrent nerve palsy (RNP), leading to
vocal folds (VF) immobility. It happens in 5% of cases, leading to high morbidity:
dysphonia, aspirations, impossibility to work. Guidelines recommend to systematically
perform a nasofibroscopy before and after surgery to check vocal fold mobility. However,
due to the decreasing number of specialists, the cost of decontamination, and discomfort
of this procedure, these guidelines are insufficiently followed.
Transcutaneous Laryngeal Ultrasonography (TLU) appears a good alternative to
nasofibroscopy in evaluating VF mobility, as assessed by the recent flourishing
literature. Our team is a leader in this research by having developed a dedicated
software, which provides objective measures of VF mobility. The aim of the present
protocol is to validate the power of TLU for the diagnosis of RNP on a large cohort of
patients operated on endocrine surgery. It is a prospective multicentric study that will
blindly compare TLU and nasofibroscopy, the latter being the gold standard. TLU is cost
effective and painless; its learning curve is fast. If validated, it may be offered as a
good alternative to nasofibroscopy in RNP detection and prognosis.
Etablissements
Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
CLCC INSTITUT GUSTAVE ROUSSY | TRESALLET Christophe | 18/10/2025 10:02:34 | Contacter | ||
AP-HP Assistance publique - Hôpitaux de Paris | 18/10/2025 10:02:34 | Contacter | |||
AP-HP - Hôpital Avicenne | |||||
AP-HP - Hôpital Cochin | |||||
AP-HP - Hôpital La Pitié-Salpêtrière | |||||
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
CHU Nantes - Clinique de chirurgie Digestive et Endocrinienne - 44093 - Nantes - France | Eric MIRALLIE | Contact (sur clinicalTrials) | |||
Hopital Pitié-Salpêtrière - 75013 - Paris - France | Contact (sur clinicalTrials) | ||||
Institut Gustave Roussy (IGR) - Villejuif - France | Dana HARTL, MD, PhD | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
1. 18 years old patient and older
2. Free informed consent of the patient obtained during the preoperative consultation
or, failing this, the day before the intervention during the preoperative
hospitalization
3. Thyroid / parathyroid surgery scheduled within 3 months, regardless of the
indication or extension
4. Affiliation to a social security system (recipient or assign) excluding AME.
Exclusion criteria
1. Known preoperative history of recurrent nerve palsy
2. History of thyroid or parathyroid surgery or cervicotomy for another pathology
3. History of laryngeal tumor or vocal folds
4. Patient under guardianship or curatorship or deprived of liberty or under judicial
protection
5. Pregnant, breastfeeding and parturient women
1. 18 years old patient and older
2. Free informed consent of the patient obtained during the preoperative consultation
or, failing this, the day before the intervention during the preoperative
hospitalization
3. Thyroid / parathyroid surgery scheduled within 3 months, regardless of the
indication or extension
4. Affiliation to a social security system (recipient or assign) excluding AME.
Exclusion criteria
1. Known preoperative history of recurrent nerve palsy
2. History of thyroid or parathyroid surgery or cervicotomy for another pathology
3. History of laryngeal tumor or vocal folds
4. Patient under guardianship or curatorship or deprived of liberty or under judicial
protection
5. Pregnant, breastfeeding and parturient women